Rheumatoid Arthritis

Latest News
August 13th 2025

Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions

August 11th 2025

Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH

July 29th 2025

Adalimumab, Etanercept Biosimilars Deliver Real-World Results for Juvenile Idiopathic Arthritis

July 9th 2025

Patients With RA and Cancer Seek More Clarity, Collaboration in Treatment Decisions

July 3rd 2025

Plant-Based Diet May Improve Stress-Related Metrics in Rheumatoid Arthritis

More News

Dentist consulting patient | Image credit: D Theron/peopleimages.com – stock.adobe.com
June 30th 2025

Dental Infections Pose Risks for Hospitalized Patients With Rheumatoid Arthritis

Hayden E. Klein
High infection rates among younger adults suggest they either delay routine dental care and only seek treatment when conditions become severe, or face more barriers.
Rheumatoid arthritis | Image credit: Evrymmnt - stock.adobe.com
June 30th 2025

Biosimilars More Cost-Effective Than Leflunomide After Methotrexate Failure in RA

Pearl Steinzor
A new economic evaluation supports updating rheumatoid arthritis guidelines to favor biosimilar disease-modifying antirheumatic drugs over leflunomide after methotrexate failure.
Doctor explaining notes to patient | Image credit: Minerva Studio – stock.adobe.com
June 30th 2025

Patient Materials for Rheumatoid Arthritis Often Miss Crucial Information

Hayden E. Klein
Researchers called for standardized health outcome descriptors to help bridge communication gaps in rheumatology care and improve shared decision-making.
Stressed older woman | Image credit: InsideCreativeHouse – stock.adobe.com
June 24th 2025

Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide

Hayden E. Klein
Osteoarthritis leads the burden, projected to affect 50% of postmenopausal women by 2045.
RA burden | Image credit: Skin and Cancer Institute
June 16th 2025

Disparities, Worsening Inequality of Growing RA Burden, Reveals AI-Driven Study

Mary Caffrey Hayden E. Klein
A global surge in rheumatoid arthritis with local hotspots highlights the need for targeted public health interventions.
Rheumatoid arthritis in hand | Image credit: yodiyim – stock.adobe.com
June 12th 2025

Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA

Hayden E. Klein
Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately respond to conventional synthetic disease-modifying antirheumatic drugs.
The connection between anemia and mortality among patients with RA could likely be explained by inflammation, explained the researchers. | Image credit: Matthieu - stock.adobe.com
May 30th 2025

Anemia Linked With Higher Risk of All-Cause, CVD-Related Mortality in Rheumatoid Arthritis

AJMC Contributor
Iron deficiency anemia increased the risk of death from any cause, while non-iron deficiency anemia was linked with an increased risk of cardiovascular disease (CVD)-related death in rheumatoid arthritis.
Throughout the study period, the number of DALYs associated with RA increased by 82.63%, rising across all age groups. | Image credit: Evrymmnt - stock.adobe.com
May 24th 2025

Increased Incidence but Lower Mortality From RA Seen Over Last 3 Decades

AJMC Contributor
The rate of rheumatoid arthritis (RA) has increased over the last 32 years, with certain groups of interest facing higher burden, finds a new analysis.
Ultrasound may be a more viable option than other methods, such as chest radiography and spirometry, to detect lung complications in rheumatoid arthritis. | Image credit: Kate - stock.adobe.com
May 16th 2025

Lung Ultrasound Can Accurately Detect ILD in Patients With RA

AJMC Contributor
The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for detecting lung complications in patients with the autoimmune disease.
Across the rheumatoid arthritis and lupus studies, the authors observed notable differences in the way research between the 2 diseases was conducted, including the types of patients included. | Image Credit: peshkova - stock.adobe.com
May 12th 2025

Differences in Clinical Trial Participation for Rheumatoid Arthritis, Lupus

AJMC Contributor
The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial participation among patients with the 2 autoimmune diseases.
The authors wanted to better understand the problem of avoidable hospitalizations among people with rheumatoid arthritis. | Image credit: everythingpossible - stock.adobe.com
May 8th 2025

Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

Jared Kaltwasser
Individuals with rheumatoid arthritis face a higher risk of hospitalization for heart failure and pulmonary edema, a new report found.
The complex interplay between RA and metabolic health can have a significant impact on morbidity and mortality and thus deserves attention, authors of a new review argued. | Image credit: 9nong - stock.adobe.com
April 30th 2025

Assessing the Complex Interplay Between Metabolic Dysfunction and Rheumatoid Arthritis

Jared Kaltwasser
Many studies have examined how rheumatoid arthritis therapy affects the risk of metabolic comorbidities.
RA results from immune system disfunction, which differentiates the disease from osteoporosis, which results from wear-and-tear over time | image credit: doucefleur - stock.adobe.com
April 29th 2025

Personalized, Interdisciplinary Care Elevates RA Treatment

Kyle Munz
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
The investigators said wide-scale clinical trials will be required to collect and analyze patient-stratification data. At present, they said, achieving true precision medicine in RA remains something of a “moonshot” goal. | Image credit: MicroOne - stock.adobe.com
April 29th 2025

In Rheumatoid Arthritis, Precision Medicine Remains "Moonshot" Goal

Jared Kaltwasser
Efforts to more precisely select appropriate therapy for individual patients with rheumatoid arthritis have not yet yielded a clear-cut strategy, a new review finds.
Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com
April 28th 2025

Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

Jared Kaltwasser
New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis.
Elderly woman holding her hands | Image credit: Evrymmnt - stock.adobe.com
April 25th 2025

Clinical, Real-World Data Support Importance of Tocilizumab for RA

AJMC Contributor
Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular benefits in recent studies.
ILD | Image Credit: PH alex aviles - stock.adobe.com
November 20th 2024

Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

Brooke McCormick
This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Arthritis in hands - stockdevil - stock.adobe.com
July 20th 2024

Persistently Active Rheumatoid Arthritis Linked With Socioeconomic Factors

Lana Pine
Factors independently associated with persistently active RA included age, gender, previous or current smoking status, and social deprivation.
The review identified several challenges to quality rheumatoid arthritis treatment, along with potential interventions to improve care. | Image Credit: MicroOne - stock.adobe.com
July 18th 2024

Gaps in Rheumatoid Arthritis Care Quality Exist in North America

Rose McNulty
A literature review plus in-person visits helped identify barriers to quality rheumatoid arthritis care, as well as effective interventions to improve care quality.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo